This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
March 1, 2012 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the Company's senior management team will host a conference call and live audio webcast on
Thursday, March 8, 2012 at
11 a.m. ET to discuss fourth quarter and full-year 2011 financial results.
Interested participants and investors may access the conference call at
11 a.m. ET by dialing 866-277-1181 (U.S./
Canada) or 617-597-5358 (international); participant code 82583482. An audio webcast can be accessed by logging on to the Investors and Media section under the Events tab of the Unigene web site,
A telephonic replay of the call will be available for two weeks beginning at
2 p.m. ET on
March 8. Access numbers for this replay are 888-286-8010 (U.S./
Canada) and 617-801-6888 (international); participant code 18902945. The webcast replay will remain available in the Investors section of the Unigene Laboratories web site for 30 days.
About Unigene Laboratories, Inc.
Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.
Investor Contact:Unigene Laboratories, Inc.
Jenene Thomas VP, Investor Relations and Business Administration 973-265-1107
firstname.lastname@example.orgMedia Contact:Tiberend Strategic Advisors, Inc.
Jason Rando /
SOURCE Unigene Laboratories, Inc.